# FDA Inspection 1219041 - Haydar A. Frangoul, MD  Program Director - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/haydar-a-frangoul-md-program-director/0929f120-cea4-4654-bee2-06e3305594ff
Source feed: FDA_Inspections

> FDA Inspection 1219041 for Haydar A. Frangoul, MD  Program Director on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219041
- Company Name: Haydar A. Frangoul, MD  Program Director
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 815013 - 2013-01-09](https://www.keypedia.com/records/fda_inspections/haydar-a-frangoul-md-program-director/d46db84a-5856-44e3-a677-013abc6cee8c)

Company: https://www.keypedia.com/companies/haydar-a-frangoul-md-program-director/9d510fbd-0be6-4a20-837b-7f6e0c784cde

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d